AGBA Acquisition (AGBAW) has had the highest return since January 1, 2024 by a US stock, returning 5,147.5%.
ASSET | % RETURN |
---|---|
AGBA Acquisition (AGBAW) | 5,147.54% |
Nexalin Technology (NXLIW) | 2,590.14% |
Fitell Corporation Ordinary Shares (FTEL) | 1,202.63% |
SRAX (SRAX) | 1,123.78% |
Codere Online Luxembourg SA Warrants (CDROW) | 1,031.54% |
Palladyne AI (PDYNW) | 999% |
Bone Biologics Corp Warrants (BBLGW) | 967.45% |
GeneDx (WGS) | 965.93% |
AdTheorent (ADTHW) | 820.81% |
Versus Systems (VSSYW) | 766.67% |
OneMedNet (ONMDW) | 736.67% |
Corbus Pharmaceuticals (CRBP) | 733.61% |
Binah Capital Group, Inc Warrants (BCGWW) | 682.61% |
iPower (IPW) | 633.33% |
LENZ Therapeutics (LENZ) | 615.75% |
AGBA Acquisition (AGBA) | 575.32% |
Armada Acquisition Corp I Warrant (AACIW) | 550% |
Mediaco (MDIA) | 548.84% |
Liberty Resources Acquisition Corp Warrant (LIBYW) | 542% |
Kernel (KRNLW) | 513.21% |
Landos Biopharma (LABP) | 511.47% |
Elevation Oncology (ELEV) | 498.15% |
Digital Health Acquisition Corp Warrant (DHACW) | 492.59% |
Zivo Bioscience (ZIVO) | 491.85% |
Barnes & Noble Education (BNED) | 472.85% |